The numbers paint a telling picture. In the United States of the 1950s there were between 3 million and 4 million annual cases of measles, a highly infectious virus that causes severe flu-like symptoms and a spreading red rash. Roughly 48,000 of those infected each year were hospitalized, and 400 to 500 died. By 2000, […]
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard Clinical and Translational Science Center convened an international panel of experts at the Brocher Foundation in Switzerland for a workshop entitled “Clinical Trial Recruitment: Problems, Misconceptions, and Possible Solutions,” on Jan. 19-21.
In a move that caught many observers off guard, the U.S. Supreme Court last week announced it would review one of four cases currently challenging provisions of the Patient Protection and Affordable Care Act (ACA). Currently, qualified consumers can receive tax subsidies to help them purchase health insurance through the federal- or state-run exchanges. But the plaintiffs […]
UCLA School of Law and Harvard Law School have announced the inauguration of the UCLA-Harvard Food Law and Policy Conference, a joint annual conference that will focus on issues in the food system from a legal perspective. The conference will alternate each year between Los Angeles and Cambridge. The conference is intended to provide a […]
Smart phones and other mobile devices have the potential to transform healthcare, improving medical outcomes, reducing errors, and broadening access to healthcare. The Food and Drug Administration must continue to have jurisdiction over these “mobile health” or “mHealth” innovations to address emerging risks, according to I. Glenn Cohen, Nathan G. Cortez, and Aaron S. Kesselheim, […]
Cass Sunstein opened the 2014 Behavioral Economics, Law, and Health Policy Conference with a keynote address called “Choosing Not to Choose.” His talk set the tone for the two-day conference organized by The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, which drew nearly 200 lawyers, public health professionals, economists, and health policy analysts to the campus from May 2-3.
The first volume of the Journal of Law and the Biosciences (JLB) was recently published by Oxford University Press. The new peer-reviewed, open access, online journal is a co venture between Duke University, Stanford University and Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics. JLB focuses on cutting-edge scholarship at the intersection of law […]